Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

NCT00176488 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

31

Enrollment

OTHER

Sponsor class

Stopped Competing studies

Conditions

Breast Cancer

Interventions

DRUG: epirubicin
DRUG: vinorelbine

Sponsor

University of Medicine and Dentistry of New Jersey

Collaborators

[object Object]